by Biotechnology Focus •
November 10, 2014 •
Business Focus, Outsourcing, Policy/Regulatory/IP, Uncategorized •
Comments (0) •
A technician verifies labelling on an elastomeric device against the work order. (CNWGroup/Baxter Corporation)
Mississauga, ON – Baxter Corporation says it is investing $10 million to build a new facility in Mississauga, ON for its Centralized Intravenous Admixing Pharmacy Service (CIVA).
Comments are closed.
© 2017 Biotechnology Focus™
Powered by Wordpress. Designed by Themnific™